{"id":801033,"date":"2025-01-15T08:35:09","date_gmt":"2025-01-15T13:35:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/"},"modified":"2025-01-15T08:35:09","modified_gmt":"2025-01-15T13:35:09","slug":"autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/","title":{"rendered":"Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Live video webcast on Wednesday, January 22<\/em><br \/>\n        <sup><br \/>\n          <em>nd<\/em><br \/>\n        <\/sup><br \/>\n        <em> at 4:00 PM ET<\/em><br \/>\n        \n      <\/p>\n<p align=\"justify\">\n        <strong>THE WOODLANDS, TX, Jan.  15, 2025  (GLOBE NEWSWIRE) &#8212; <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HLoa-vgT6i0XxewT0mDCMUSDlCA0_0LthSr5Qo1cGAS4nupRnqjAUaNYFR9Dk3JCkYhYLPr0UR4K-bHm3Vah1njml19ifvPD5Ocr5m3nFTo=\" rel=\"nofollow\" target=\"_blank\">Autonomix Medical, Inc.<\/a> (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it will participate in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-JCpf2u9A7_iijE8nacRXWV7cHktkFbrct2SE7FeHNp10o5LAgBMAHoqc9D8FQpreib6zsWH1fZjZhj_uLKwCjrTd6O_ykq9yZJZDtAswh5iY2E4RNZHmS7PjJ_z0_mIK5CAAM5EmwtXABDTQ4WHFLAIY9V10ZHdCNbV_iPo_cc=\" rel=\"nofollow\" target=\"_blank\">Virtual Investor Closing Bell Series<\/a> on Wednesday, January 22, 2025 at 4:00 PM ET.<\/p>\n<p align=\"justify\">As part of the event, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PGkfL5sLr51k_k10YV8ZjQOeKBQIEv79_Ijvg2VHIsZDrJsKgai_USkr2laOECPnnmNSfO-7aWFHadqw-hEz2VV3kE4GvXkpN-CfPRF1_wYVBKwmgMCXdvamAq89CauyC5s0659SQvK3068MkiVB1A==\" rel=\"nofollow\" target=\"_blank\">Brad Hauser, Chief Executive Officer<\/a> of Autonomix, will provide a corporate overview and business outlook. In addition to the moderated discussion, investors and interested parties will have the opportunity to submit questions live during the event. The Company will answer as many questions as possible in the time allowed.<\/p>\n<p align=\"justify\">A <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_q6xnSy3AyBmJphzTrG7muMo9OFoHxZs2UfFzbB09CZXyrmWJR4ujuNtlGn2JrWwS5LuAThb13QNjGvXgW8O-29EGFgSXkTM7Ftll7UG8Cwityu32knqWfqwVNVRDCiZBglsT52oCGR0iu3zSylp4Q==\" rel=\"nofollow\" target=\"_blank\">live video webcast<\/a> will be available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ovm3iJ_TQCY0UltOsjruRIQPGKA5Ghw1Su29TYxF1OrlaMBm0539eXaFuj7EeqADOiBxxp3GkXZMcXFQYyoafO5D6vQ8lCHBCqLNhtvYnxo=\" rel=\"nofollow\" target=\"_blank\">Events<\/a> page under the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sYjeEVLMviifrilCyYbpPjgz6Yc-Y89TOYt4WjxrVjpLdb9R0gr1WMJj1ce0CRMi5HkX_mzIVbfMP20bX4zwFw==\" rel=\"nofollow\" target=\"_blank\">Investors<\/a> section of the Company\u2019s website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YCypd_ZN4ImFH8J6v-APNCotmzIcDxBw0o4lAHHqPAWd0S1dJbQIUzq5i0oYesCxHPAug5LDtsDbgQOamx74pw==\" rel=\"nofollow\" target=\"_blank\">autonomix.com<\/a>). A webcast replay will be available two hours following the live event and will be accessible for 90 days.<\/p>\n<p align=\"justify\">\n        <strong>About Autonomix Medical, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company\u2019s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.<\/p>\n<p align=\"justify\">We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.<\/p>\n<p align=\"justify\">For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YCypd_ZN4ImFH8J6v-APNHTr3gckzbNjRfzwyfBiTIsOxKt5pSWGbhKos28I15iQERF1z6Y9UUHNQdqoaBRbcQ==\" rel=\"nofollow\" target=\"_blank\">autonomix.com<\/a> and connect with the Company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cX7lidOGjPpqcodp-mWhn1XYWTi4Gyny-PytHs_ePt1_1i6bg4xm_MOYQ3gcZWJ2L76QMIFfoJdsvrQGBffgKQ==\" rel=\"nofollow\" target=\"_blank\">X<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TRkbVI5xseiZ-LEEoQmOiaTJ9-rMxYPIx0yb1pXtKYOHx1Cw7sI9AZJ2pLITobNDwFc1bH4asYxbUQ2p0mUaREPO2N_Aj392uzRQFF4AlMpLdAKKFEI8GLjSSc1oDmfz\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qkumwjhzq9t-s2G5RlV07393J56hURRFIeLzIsLgEqQSbhQ9F9TkpGY9zgxOkfZdeHUmZN_qf-dmt7MCv8ZcfMSk3JCdSxUxdMn7_KtFVA0=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NbUEdLq8bOryifuZfTtsQSdYSR1bdOdJ5nbBUNXFEntPD6JjZO3jjLXwdKZ68j73pJ6ApUs1MYrcf_ap5OYHO1CcMZDzlGnetbm_MazoulJqHnThCq52Qvrm4kv9smnd\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor and Media Contact<\/strong>\n      <\/p>\n<p align=\"justify\">JTC Team, LLC<br \/>Jenene Thomas\u00a0<br \/>908.824.0775<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YCypd_ZN4ImFH8J6v-APNKwT_QZhW2Lr2Y2ju3VgfJtS4MQjFd63RtJmEkZN7O7fGoUnnJnDz8QKNtV95WZ93jOt90XktAVmY7P89u8nRjk=\" rel=\"nofollow\" target=\"_blank\">autonomix@jtcir.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjI3MSM2Njk1MDMwIzUwMDExOTk5Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTg0Y2I5ZWItODAxMy00NzZmLWJjMGEtMzFmNzkwZTBkYzVjLTUwMDExOTk5Mg==\/tiny\/Autonomix-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Live video webcast on Wednesday, January 22 nd at 4:00 PM ET THE WOODLANDS, TX, Jan. 15, 2025 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc. (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it will participate in the Virtual Investor Closing Bell Series on Wednesday, January 22, 2025 at 4:00 PM ET. As part of the event, Brad Hauser, Chief Executive Officer of Autonomix, will provide a corporate overview and business outlook. In addition to the moderated discussion, investors and interested parties will have the opportunity to submit questions live during the event. The Company will answer as many &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-801033","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Live video webcast on Wednesday, January 22 nd at 4:00 PM ET THE WOODLANDS, TX, Jan. 15, 2025 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc. (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it will participate in the Virtual Investor Closing Bell Series on Wednesday, January 22, 2025 at 4:00 PM ET. As part of the event, Brad Hauser, Chief Executive Officer of Autonomix, will provide a corporate overview and business outlook. In addition to the moderated discussion, investors and interested parties will have the opportunity to submit questions live during the event. The Company will answer as many &hellip; Continue reading &quot;Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-15T13:35:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjI3MSM2Njk1MDMwIzUwMDExOTk5Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series\",\"datePublished\":\"2025-01-15T13:35:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/\"},\"wordCount\":357,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMjI3MSM2Njk1MDMwIzUwMDExOTk5Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/\",\"name\":\"Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMjI3MSM2Njk1MDMwIzUwMDExOTk5Mg==\",\"datePublished\":\"2025-01-15T13:35:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMjI3MSM2Njk1MDMwIzUwMDExOTk5Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMzMjI3MSM2Njk1MDMwIzUwMDExOTk5Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/","og_locale":"en_US","og_type":"article","og_title":"Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series - Market Newsdesk","og_description":"Live video webcast on Wednesday, January 22 nd at 4:00 PM ET THE WOODLANDS, TX, Jan. 15, 2025 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc. (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it will participate in the Virtual Investor Closing Bell Series on Wednesday, January 22, 2025 at 4:00 PM ET. As part of the event, Brad Hauser, Chief Executive Officer of Autonomix, will provide a corporate overview and business outlook. In addition to the moderated discussion, investors and interested parties will have the opportunity to submit questions live during the event. The Company will answer as many &hellip; Continue reading \"Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-15T13:35:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjI3MSM2Njk1MDMwIzUwMDExOTk5Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series","datePublished":"2025-01-15T13:35:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/"},"wordCount":357,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjI3MSM2Njk1MDMwIzUwMDExOTk5Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/","name":"Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjI3MSM2Njk1MDMwIzUwMDExOTk5Mg==","datePublished":"2025-01-15T13:35:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjI3MSM2Njk1MDMwIzUwMDExOTk5Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMzMjI3MSM2Njk1MDMwIzUwMDExOTk5Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-to-participate-in-the-virtual-investor-closing-bell-series\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/801033","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=801033"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/801033\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=801033"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=801033"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=801033"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}